| Medical News | |
| Articles | |
| Events | |
| Guidelines | |
| Videos Library | |
| Diseases |
| Follow us : |
-
Doctors (525026):
Luai Al Bakour -
Pharmacies (142856):
El Temamy Pharmacy -
Factories (9503):
Akoni Hijyen Teknolojileri Sanayi ve Dış Ticaret LTD. ŞTİ -
Laboratories (19243):
Britton Chance Center for Biomedical Photonics -
Hospital (68158):
City Hospital -
Agencies (6416):
Arabian Trade Center - ATC -
Medical Facility (32206):
Legality International. (Pvt.) Ltd.
Agurin
Main
You must sign in to use this servcieFeedback - Please use the form below to send your query or comment
You must sign in to use this servcie
Info
|
Indications: Reduction of fever. Relief of aches & pains associated w/ flu, common colds, tonsilitis, teething pains & post-immunization reactions. |
|||
|
Contraindications: Anemia, cardiac, pulmonary, renal & hepatic diseases. |
|||
|
Adverse reactions: Skin rashes or minor GI disturbances. |
|||
|
Interactions: Acetaminophen is metabolized (eliminated by conversion to other chemicals) by the liver. Therefore drugs that increase the action of liver enzymes that metabolize acetaminophen [for example, carbamazepine (Tegretol), isoniazid (INH, Nydrazid, Laniazid), rifampin (Rifamate, Rifadin, Rimactane)] reduce the levels of acetaminophen and may decrease the action of acetaminophen. Doses of acetaminophen greater than the recommended doses are toxic to the liver and may result in severe liver damage. The potential for acetaminophen to harm the liver is increased when it is combined with alcohol or drugs that also harm the liver. Cholestyramine (Questran) reduces the effect of acetaminophen by decreasing its absorption into the body from the intestine. Therefore, acetaminophen should be administered 3 to 4 hours after cholestyramine or one hour before cholestyramine . Acetaminophen doses greater than 2275 mg per day may increase the blood thinning effect of warfarin (Coumadin) by an unknown mechanism. Therefore, prolonged administration or large doses of acetaminophen should be avoided during warfarin therapy |
|||
|
Warnings: Renal or hepatic impairment. |
|||
|
Form: TABLET |
Dosage and Administration
You must sign in to use this servcieTechnical Description
You must sign in to use this servcieDr. Tahsin Martini
Yaser Habrawi , F.R.C.S.Ed
Dr . Dirar Abboud
Dr. Samer Al-Jneidy
Dr. Hani Najjar
Dr. Faisal Dibsi
Samir Moussa M.D.
Dr. Talal Sabouni









